Pablo Cabello Albendea

Dendrico SL is a holding company engaged in the development and manufacture of nanotechnology systems. These find applications in the fields of diagnostics, therapeutics, and medical research. The company was founded in 2005 and is headquartered in Madrid, Spain.

Inversiones Jalabun SICAV SA is an open-end investment company which primarily invests in equity securities. The company was founded on February 3, 1999 and is headquartered in Madrid, Spain.

Venter Pharma SL develops and manufactures pharmaceutical products. The firm’s products include lactest and xylossay. The company was founded by Juan Jose Aragon Reyes and Alfonso Fernandez Alvarez Mayoralas in 2003 and is headquartered in Alcobendas, Spain.

Biocross SL designs and develops diagnostic products for neurodegenerative diseases. Its products include multiparametric blood tests and biomarkers for identifying amytrophic lateral sclerosis, Parkinson's disease, and Alheimer's. The company was founded on January 26, 2005 and is headquartered in Boecillo, Spain.

Traslational Cancer Drugs Pharma SL engages in the discovery and development of therapeutic solutions for the treatment of cancer. Its TCD-717 choline kinase alpha inhibitor is an intravenously-administered small molecule designed to target cancer cells. It also provides technology in-licensing and out-licensing services. The company was founded by Juan Carlos San Juan on July 29, 2005 and is headquartered in Valladolid, Spain.

Raman Health Technologies SL researches and develops laser and spectroscopy-based diagnostic technology. The company was founded by Perez F. Rull on February 14, 2013 and is headquartered in Boecillo, Spain.

Advanced Marker Discovery SL is a holding company engaged in the development of diagnostic solutions in the field of oncology. Its pipeline consists of tests for the prognosis and prediction of colon, lung, and prostate cancer. The company was founded on June 29, 2010 and is headquartered in Valladolid, Spain.

Cross Road Biotech Inversiones Biotecnologicas SGEIC SA (Cross Road Biotech Inversiones Biotecnologicas) is a venture capital firm founded in 2001 by Enrique Castellon Leal. The firm is headquartered in Madrid, Spain.